familial amyloid neuropathies familial amyloidotic neuropathies neuropathic heredofamilial amyloidosis familial amyloid polyneuropathy rare group autosomal dominant diseases wherein autonomic nervous system andor nerves compromised protein aggregation andor amyloid fibril aggregation one precursor protein leads peripheral neuropathy andor autonomic nervous system dysfunction proteins include transthyretin attr commonly implicated protein apolipoprotein due rareness types familial neuropathies transthyretin amyloidogenesisassociated polyneuropathy probably considered fapi fapii associated senile systemic amyloidosis abbreviated ssa also associated transthyretin aggregation fapiii also known iowatype involves apolipoprotein fapiv also known finnishtype involves fibrinogen apolipoprotein lysozyme associated closely related condition familial visceral amyloidosis diagnosis confirmed blood tests organ biopsies tissue biopsies genetic testing also used confirm mutation ttr gene although people hattr gene mutation may experience symptoms liver transplantation proven effective attr familial amyloidosis due european medicines agency approved tafamidis fda rejected application marketing approval us basis clinical trial data show efficacy based functional endpoint fda requested clinical httpsenwikipediaorgwikifamilialamyloidneuropathy